Lv1
58 积分 2023-02-17 加入
Rationale for anti-CD137 cancer immunotherapy
4天前
已完结
RIPTACs for Precision Cancer Therapy: A Novel Modality with the Inspiration of HLD-0915 as the First Candidate in Clinical Trials
25天前
已完结
AI-driven discovery of GPNMB CAR T cells as a multi-cancer therapy
28天前
已完结
SLAMF6 as a drug-targetable suppressor of T cell immunity against cancer
28天前
已完结
ANKRD11 deficiency reprograms CD8+ T cell differentiation to enhance immunity in chronic infection and cancer
29天前
已完结
AI-Driven Design Platforms of Next-Generation Antibody Therapeutics
1个月前
已完结
Progranulin deficiency-induced lysosomal dysfunction drives maladaptive myeloid cell states through the MITF/TFE transcription factors
2个月前
已完结
Pharmacokinetics, Lymph Node Uptake, and Mechanistic PK Model of Near-Infrared Dye-Labeled Bevacizumab After IV and SC Administration in Mice
2个月前
已完结
Therapeutic Enhancement of IL-2 Through Molecular Design
3个月前
已完结
Crystal structure of the IL-2 signaling complex: Paradigm for a heterotrimeric cytokine receptor
3个月前
已完结